BioLineRx Ltd (BLRX)

[rocketeer357]

I'm not convinced there's much value in referencing a stale Maxim forecast. The Yahoo info is more in line with what the company itself said on 14 May 2019:

Turning to cash, the company held $40.6 for million in cash, cash equivalents and short-term bond deposit as of March 31, 2019 as compared to $30.2 million as of December 31, 2018. In February 2019 we completed the public offering with gross proceeds of $15.4 million, which provide us with a cash towards the first half of 2021, a runway of more than two years sufficient to fund our operations to our most significant clinical milestone.

I'm not happy at all that BLRX has effectively gone ahead with a reverse split. And with bio stocks, there can be no guarantee that the company won't raise $$ at any point. Just trying to understand the reasons for your assertion that that BLRX will run out of cash by the end of 2019 when all evidence suggests otherwise.